Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Jan Piťha"'
Autor:
Zuzana Tucanova, Peter Ivak, Peter Wohlfahrt, Marek Pol, Daniel Hlavacek, Miroslav Konarik, Ondrej Szarszoi, Ivan Netuka, Jan Pitha
Publikováno v:
ESC Heart Failure, Vol 8, Iss 5, Pp 4288-4295 (2021)
Abstract Aims Recipients of left ventricular assist devices (LVAD) are exposed to increased risk of adverse clinical events. One of the potential contributing factors is non‐pulsatile flow generated by LVAD. We evaluated the association of flow pat
Externí odkaz:
https://doaj.org/article/710e3f13c191446cac6d34c8cb366b62
Autor:
Peter Wohlfahrt, Dominik Jenča, Vojtěch Melenovský, Marek Šramko, Martin Kotrč, Michael Želízko, Jolana Mrázková, Věra Adámková, Jan Pitha, Josef Kautzner
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundLeft ventricular ejection fraction (EF) is an independent predictor of adverse outcomes after myocardial infarction (MI). However, current data on trajectories and determinants of EF are scarce. The present study aimed to describe the epide
Externí odkaz:
https://doaj.org/article/de1df35f829b4df89220837b1c0e227f
Autor:
Peter Wohlfahrt, MD, PhD, Dominik Jenča, MD, Vojtěch Melenovský, MD, PhD, Jolana Mrázková, Mgr, Marek Šramko, MD, PhD, Martin Kotrč, MD, Michael Želízko, MD, Věra Adámková, MD, PhD, Francisco Lopez-Jimenez, MD, MSc, MBA, Jan Piťha, MD, PhD, Josef Kautzner, MD, PhD
Publikováno v:
Mayo Clinic Proceedings: Digital Health, Vol 2, Iss 3, Pp 352-360 (2024)
Objective: To evaluate the effect of smart device-based telerehabilitation on Vo2peak in patients after myocardial infarction. Patients and Methods: This was a pilot, single-center, randomized, cross-over study with a 3-month intervention. One month
Externí odkaz:
https://doaj.org/article/c54556d7a7594845a4ee28d4bb58a0e9
Autor:
Pavlína Piťhová, Michaela Cichrová, Milan Kvapil, Jaroslav A. Hubáček, Dana Dlouhá, Jan Piťha
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-14 (2024)
Abstract Background The associations of risk factors with vascular impairment in type 1 diabetes patients seem more complex than that in type 2 diabetes patients. Therefore, we analyzed the associations between traditional and novel cardiovascular ri
Externí odkaz:
https://doaj.org/article/752b8015a7cf480b85de35b88bdc8d3a
Autor:
Peter Wohlfahrt, Dominik Jenča, Vojtěch Melenovský, Josef Stehlik, John A. Spertus, Jolana Mrázková, Marek Šramko, Martin Kotrč, Michael Želízko, Věra Adámková, Jan Piťha, Josef Kautzner
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 2 (2024)
Background Heart failure is a common complication after myocardial infarction (MI) and is associated with increased mortality. Whether remote heart failure symptoms assessment after MI can improve risk stratification is unknown. The authors evaluated
Externí odkaz:
https://doaj.org/article/8e6d6cd5fcf94377a1ee6793519a8c0f
Autor:
Peter Wohlfahrt, Dominik Jenča, Vojtěch Melenovský, Petr Jarolím, Dana Dlouhá, Marek Šramko, Martin Kotrč, Michael Želízko, Jolana Mrázková, Jan Piťha, Věra Adámková, Josef Kautzner
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 6 (2023)
Background The hypocretin/orexin system has been shown to play a role in heart failure. Whether it also influences myocardial infarction (MI) outcomes is unknown. We evaluated the effect of the rs7767652 minor allele T associated with decreased trans
Externí odkaz:
https://doaj.org/article/44d740c12e5a41ca9cb54fe108d3ebbf
Autor:
Vladimír Teplan, Andrea Mahrova, Jan Piťha, Jaroslav Racek, Robert Gürlich, Vladimír Teplan Jr, Ivo Valkovsky, Milena Štollova
Publikováno v:
Kidney & Blood Pressure Research, Vol 39, Iss 4, Pp 289-298 (2014)
Background/Aims: To assess, in a prospective cohort study of 238 renal transplant patients, our hypothesis that elevated ADMA levels may be influenced by physical exercise and obesity. Methods: Blood samples before and after six months were obtained
Externí odkaz:
https://doaj.org/article/50278f440da847968074563f7a9b2d37
Autor:
Peter Wohlfahrt, Dominik Jenča, Josef Stehlik, Vojtěch Melenovský, Jolana Mrázková, Vladimír Staněk, Jiří Kettner, Marek Šramko, Michael Želízko, Věra Adámková, Jan Piťha, Josef Kautzner
Publikováno v:
Clinical Research in Cardiology. 112:39-48
Recent advances in therapy led to a significant decrease in mortality and morbidity after myocardial infarction (MI). However, little is known about quality of life (QoL) after MI. We examined heart failure (HF)-related quality-of-life (QoL) impairme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3f788662798e0d9abba1f4efa7748d3
https://doi.org/10.1007/s00392-022-02008-z
https://doi.org/10.1007/s00392-022-02008-z
Autor:
Věra Boháčová, Jan Piťha
Publikováno v:
Vnitřní lékařství. 65:788-793
Majority of patients with peripheral artery disease (PAD) are affected by coronary artery disease and other vascular complications, often fatal. PAD is, therefore, powerful indicator of a very high risk of death. The main risk factors are smoking and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2cda5fc97f3559dd9cb7b4c160fd2dd
https://doi.org/10.36290/vnl.2019.137
https://doi.org/10.36290/vnl.2019.137
Autor:
Jaroslav A. Hubacek, Vera Adamkova, Vera Lanska, Vladimir Stanek, Jolana Mrazkova, Marie Gebauerova, Jiri Kettner, Josef Kautzner, Jan Pitha
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 12, Iss 8, Pp n/a-n/a (2024)
Abstract Background The highest mortality and morbidity worldwide is associated with atherosclerotic cardiovascular disease (ASCVD), which has in background both environmental and genetic risk factors. Apolipoprotein L1 (APOL1) variability influences
Externí odkaz:
https://doaj.org/article/c86151691d714cd7a63d5159a8791975